Social Security 2027 cost-of-living adjustment estimate rises with gas prices

New government data shows the pace of inflation has increased, pushing up one estimate for the Social Security cost-of-living adjustment for 2027.
Earnings season could finally give the stock market some good news. Here’s what’s ahead

Given a strong earnings backdrop, investors have been optimistic that companies can weather an energy shock — so long as there is a quick resolution to the war.
Merck shares are forming a bullish chart pattern, and a breakout could be on the horizon

The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
Merck shares are forming a bullish chart pattern, and a breakout could be on the horizon

The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer

Former Sen. Ben Sasse is taking Revolution Medicines’ daraxonrasib, which has shown promise as a treatment for pancreatic cancer.
Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer

Former Sen. Ben Sasse is taking Revolution Medicines’ daraxonrasib, which has shown promise as a treatment for pancreatic cancer.
Crypto treasury firms deserve closer attention and these four are buying opportunities, says TD Cowen

TD Cowen is initiating coverage on four crypto treasury firms – public companies who make it their job to buy and hold crypto to increase shareholder value.
Stocks making the biggest moves midday: Palantir, Marvell, CoreWeave, Zscaler & more

Here are the names making headlines in midday trading.
Michael Burry says he’s still betting against Palantir after Trump post boosts stock

The investor of the “Big Short” fame said he continues to hold long-dated put options on the artificial intelligence software firm.
Trump praises Palantir with stock down 14% this week as Iran conflict drags on

Palantir’s Maven platform have reportedly been used in the U.S. military campaign in Iran.